Bronchitis - chronic
Methodology & AI Transparency ⓘ
Bronchitis - chronic Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code J42 in Lungs & Asthma, Bronchitis - chronic requires FeNO/eosinophil Type-2 inflammation in Bronchitis - chronic (J42: phenotyping) so specialists can calibrate treatment intensity against Blood Eosinophil Count [Bronchitis - chronic J42] benchmarks.
- 2 Real-world patient consensus: Clinical coding for Bronchitis - chronic uses ICD-10 J42 across Lungs & Asthma specialty care.
- 3 Typical cash cost range: Primary evaluation for Bronchitis - chronic incorporates FeNO/eosinophil Type-2 inflammation in Bronchitis - chronic (J42: phenotyping) and symptom diary review.
- 4 Top reported side effects / signs: Follow-up benchmark in Bronchitis - chronic: maintaining Blood Eosinophil Count [Bronchitis - chronic J42] within < 150 cells/uL (phenotyping marker) (J42).
Ask our AI Specialists anything about Bronchitis - chronic
What Is Bronchitis - chronic?
Cataloged under federal diagnostic code J42 in Lungs & Asthma, Bronchitis - chronic requires FeNO/eosinophil Type-2 inflammation in Bronchitis - chronic (J42: phenotyping) so specialists can calibrate treatment intensity against Blood Eosinophil Count [Bronchitis - chronic J42] benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Bronchitis - chronic (code J42) is dynamic expiratory airflow in Bronchitis - chronic (J42: limitation), which Asthma, COPD & Respiratory Disease clinicians address while surveilling Blood Eosinophil Count [Bronchitis - chronic J42] (< 150 cells/uL (phenotyping marker) (J42)).
Common Symptoms & Clinical Signs
- • Presentation of Bronchitis - chronic (J42): declining stair-climbing stamina in Bronchitis - chronic (J42: or frequent rescue)
- • Secondary Bronchitis - chronic clinical sign: episodic wheezing, expiratory in Bronchitis - chronic (J42: chest tightness, or)
- • Symptom flares in Bronchitis - chronic correlating with Blood Eosinophil Count [Bronchitis - chronic J42] deviation outside < 150 cells/uL (phenotyping marker) (J42)
- • Functional lungs & asthma impact requiring FeNO/eosinophil Type-2 inflammation in Bronchitis - chronic (J42: phenotyping) evaluation (J42)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Bronchitis - chronic Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | J42 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Asthma, COPD & Respiratory Disease | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Blood Eosinophil Count [Bronchitis - chronic J42] | < 150 cells/uL (phenotyping marker) (J42) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Spirometry FEV1 / in Bronchitis - chronic (J42: FVC Ratio) | >= 0.75 (FEV1 >= 80% predicted) (J42) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fractional Exhaled Nitric in Bronchitis - chronic (J42: Oxide (FeNO)) | < 25 ppb (J42) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Bronchitis - chronic
Treatment selection for Bronchitis - chronic depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Bronchitis - chronic)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Real-world benefits and safety of DW1601 in patients with acute bronchitis: a: What a 204-Participant Study Found DW1601 is superior to DW16011 or P. The Korean journal of internal medicine • 2022-11-15 • Phase III Randomized Trial | N = 204 | 88/100 | PMID 36153858 ↗ |
| What the Latest Evidence Really Says About Heart and blood vessel outcomes in patients with COPD-OSA overlap However, it is worth noting that the findings are limited by the considerable heterogeneity of the studies, all of which were observational and retrospective in nature. Sleep medicine reviews • 2022-06-15 • Meta-Analysis | Multi-cohort | 86/100 | PMID 35413500 ↗ |
Bronchitis - chronic Patient Community & “People Like Me” Threads
Filter Bronchitis - chronic community threads and patient logs by age, biological sex, dosage, and treatment duration.